News from emmaus medical, inc

Jan 07, 2014, 08:00 ET

Emmaus Medical Announces Completion Of All Patient Visits For Its Phase 3 Clinical Trial For Treatment Of Sickle Cell Disease

 Emmaus Medical, Inc. (the "Company," or "Emmaus"), a biopharmaceutical company engaged in the discovery, development and commercialization of...

May 09, 2013, 08:00 ET

Former FDA Official Tim Cote Joins Emmaus Medical as Regulatory Advisor

Timothy Cote, M.D., MPH, former director of the Office of Orphan Product Development of the U.S. Food and Drug Administration, has joined Emmaus...

Dec 19, 2012, 16:00 ET

Emmaus Medical to Present at 6th Annual OneMedForum

Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced that Peter Ludlum, the company's executive vice...

Dec 03, 2012, 08:00 ET

Emmaus Medical Announces Completion of Enrollment for its Phase 3 Sickle Cell Disease Trial

Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced the completion of patient enrollment for its...

Nov 19, 2012, 11:00 ET

Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Company's Phase III FDA Sickle Cell Treatment Trials

Following a meeting on November 5, 2012 with the U.S. Food & Drug Administration (FDA), Dr. Yutaka Niihara offered the following remarks: "The...

Sep 13, 2012, 06:00 ET

Emmaus Medical Marks Progression of Phase 3 Sickle Cell Disease Clinical Trial During Sickle Cell Awareness Month

 In conjunction with Sickle Cell Awareness Month, Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology...

Jul 17, 2012, 09:45 ET

European Commission Grants Orphan Medicinal Product Designation for Emmaus Medical's Sickle Cell Treatment

Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology company, and subsidiary of Emmaus Life Sciences, Inc., today...

May 29, 2012, 06:00 ET

Emmaus Medical's Sickle Cell Treatment Receives Positive Opinion for Orphan Drug Status from European Medicines Agency

 Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences,...

May 18, 2010, 08:00 ET

Dr. Henry A. McKinnell Jr., Former Pfizer CEO, Joins Emmaus Medical, Inc. Board of Directors

Emmaus Medical, Inc., the privately-held pharmaceutical company developing and bringing to market a promising new treatment for sickle cell...

Dec 19, 2007, 00:00 ET

Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome

TORRANCE, Calif., Dec. 19 /PRNewswire/ -- Emmaus Medical, Inc., a Torrance, California based pharmaceutical company, announced today that it has...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge